Реблозил Луспатерсепт 25 mg 1 фл Концентрат BRISTOL MYERS Summary \r\n Luspatercept is an erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms. 
Reblozyl (luspatercept) 25 mg, original
Article:
In Stock
Summary
Luspatercept is an erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms.
- Commercial name:Реблозил
- Сhemical name:Луспатерсепт
- Dosage:25 mg
- Quantity:1 фл
- Release form:Концентрат
- Производитель:BRISTOL MYERS
No reviews yet